Although the mechanism is still unknown, it is essential to be aware of any unfavorable or deleterious effects of Mas activation in the kidney, when the therapeutic potential of ACE2/Ang (1–7)/Mas in metabolic or cardiovascular diseases is widely noticed. This evidence concerns the gene MAS1 and cardiovascular disorder.